GlassScriptPhysician profile
Sana Sultan Siddique
NPI 1558613679
$1,844.33
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $1,001 · 2021: $147 · 2022: $212 · 2023: $108 · 2024: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $597.17 | 2020 | |
| Boston Scientific Corporation | $427.12 | 2020-2022 | |
| Abbvie INC. | $401.88 | 2019-2024 | Mavyret, Viberzi, Linzess |
| Pentax of America, INC. | $143.90 | 2024 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Janssen Biotech, INC. | $54.63 | 2020-2023 | Stelara |
| E.R. Squibb & Sons, L.L.C. | $52.44 | 2022-2023 | Eliquis, Camzyos |
| Foundation Medicine, INC. | $32.89 | 2020 | |
| Intercept Pharmaceuticals, INC. | $22.18 | 2020 | |
| Olympus America INC. | $21.98 | 2024 | Endoclot Phs |
| Shionogi INC | $21.47 | 2020 | |
| Celgene Corporation | $21.31 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.91 | 2020 | |
| Ambu INC. | $14.86 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sana Siddique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.